LifeMD tirzepatide review

LifeMD is a physician-led service built around getting your medication covered by insurance, and it should be judged on that rather than on its monthly fee.

The GLP-1 programme is $75 for the first month and $149 a month thereafter, with an annual plan bringing it as low as $75 a month. That fee buys clinical care and administrative work — not medication. If your insurer declines, you pay the fee and the full medication cost separately.

What you will actually pay

Programme fee only. Branded medication cost sits on top unless insurance covers it.

For a cash payer with no coverage prospect, this is a difficult sell. You are paying $149 a month for care and then buying medication at market price. For an insured patient, it can be the cheapest arrangement on this page.

How LifeMD works

Physician-led telehealth group with a weight-management programme built around insurance coordination and branded prescriptions.

The physician-led model is genuine, and the insurance coordination is the core service rather than a marketing line. For someone with a plan that might cover a GLP-1, that work is worth real money: the difference between a covered and uncovered prescription can be a thousand dollars a month.

The facts we verified

• GLP-1 injection programme listed at $75 first month, then $149/month.
• Annual plan advertised as low as $75/month.
• Programme fee does not include medication when medication is branded and billed to insurance.
• Markets insurance coordination that can reduce semaglutide cost to roughly $25/month where coverage applies.

Every figure above was checked on 2026-09-18. Pricing in this market moves, so treat anything older than a month as a starting point rather than a quote.

Where it is strong

• Genuine clinician oversight with a physician-led model.
• Insurance work is a core part of the service, not an afterthought.
• Annual plan meaningfully reduces the programme fee.

Where it falls short

• The programme fee buys care, not medication.
• Cash-pay outcomes are far less attractive than insured ones.

How it scored

LifeMD scores 3.5 out of 5 on our published rubric, placing it 14 of 23 for tirzepatide. The weights are fixed before we look at any provider and are set out in full on how we rate.

Who it suits

Aimed squarely at insured patients. If you have already been denied, or you have no coverage at all, a flat-rate compounded programme will serve you better.

Our verdict

Strong clinical governance and real insurance advocacy, wrapped around a fee that only pays for itself if coverage comes through. Check your formulary before you sign anything.

How it compares on tirzepatide

The full reasoning behind this order is in our best tirzepatide providers guide.